Work

Supplementary Tables S1-S5 from A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses

Year: 2023

Type: supplementary-materials

Abstract: Table S1. Efficacy Table S2. Descriptive Statistics of Guadecitabine Plasma Pharmacokinetic Parameters Table S3. Descriptive Statistics of Decitabine Plasma Pharmacokinetic Parameters Table S4. Genes Tested for Methylation and Expression Analysis of Tumor Biopsies Table S5. All AEs of CTCAE Grade 3 or Higher

DOI: 10.1158/1078-0432.22463961

Authors: Daniela Matei, Sharad Ghamande, Lynda Roman, Angeles Alvarez Secord, John Nemunaitis, Merry Jennifer Markham, Kenneth P. Nephew, Simone Jueliger, Aram Oganesian, Sue Naim, Xiang Yao Su, Harold Keer, Mohammad Azab, Gini F. Fleming

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361885892

Cites:

Cited by:

Related to: 10